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The structure and function of the synthetic innate
defense regulator peptide 1018 was investigated.
This 12 residue synthetic peptide derived by
substantial modification of the bovine cathelicidin
bactenecin has enhanced innate immune regulatory
and moderate direct antibacterial activities. The
solution state NMR structure of 1018 in zwitterionic
dodecyl phosphocholine (DPC) micelles indicated
an a-helical conformation, while secondary struc-
tures, based on circular dichroism measurements,
in anionic sodium dodecyl sulfate (SDS) and phos-
pholipid vesicles (POPC/PG in a 1:1 molar ratio)
and simulations revealed that 1018 can adopt
a variety of folds, tailored to its different functions.
The structural data are discussed in light of the ability
of 1018 to potently induce chemokine responses,
suppress the LPS-induced TNF-a response, and
directly kill both Gram-positive and Gram-negative
bacteria.INTRODUCTION
Host-defense peptides (HDPs) are short amphiphilic peptides
that are ubiquitous in nature, where they are an integral compo-
nent of the anti-infective defense mechanisms of insects, plants,
and highly evolved animal species with more complex immune
systems (Bowdish et al., 2005b; Mookherjee et al., 2006a; Scott
et al., 2007). They are short cationic peptides, consisting of 12
to 50 amino acid residues, with a net positive charge of +2
to +9, and a high proportion of hydrophobic residues. Some
examples include the human cathelicidin LL-37 (Bowdish et al.,
2005a), bovine indolicidin (Bowdish et al., 2005b; Rozek et al.,
2000) and bactenecin (Wu and Hancock, 1999b), the ubiquitous
a- and b-defensins (Crovella et al., 2005; Dhople et al., 2006;
Mygind et al., 2005; Sahl et al., 2005), and the bacterial-
produced antimicrobial peptides nisin (Hsueh et al., 2005) and
polymyxin B (Hancock, 2001; Zhang et al., 2000b).
HDPs are typically unstructured in solution. However, upon
contact with hydrophobic phospholipid bilayers of cell970 Chemistry & Biology 17, 970–980, September 24, 2010 ª2010 Elmembranes, these peptides characteristically adopt an amphi-
philic structure. As such, HDPs can be classified into four broad
structural groups: b sheets, a helices, loops, and extended struc-
tures (Straus and Hancock, 2006). Investigations of HDP antimi-
crobial or hemolytic activities have demonstrated that the mode
of peptide action involves either modest membrane permeabili-
zation followed by peptide translocation across the membrane
and subsequent interaction with cytoplasmic targets, or disrup-
tion of the cell membrane and bacterial lysis. When the peptides
act by disrupting the membrane, they perturb the physical integ-
rity of the bacterial membrane by thinning or transient poration.
Although often regarded as direct antimicrobial agents, natural
HDPs often display rather weak or ablated antimicrobial activi-
ties under physiological conditions (being antagonized by high
mono- and divalent cation concentrations and by polyanions);
thus, only those peptides that can directly kill microbes under
physiological conditions should be termed antimicrobial
peptides. Those that are able to kill microbes throughmodulation
of the immune system (with or without antimicrobial activity) are
termed HDPs.
It is increasingly appreciated that the role of HDPs as host-
defense molecules may be better represented by their ability to
modulate the host immune response via a range of mechanisms
(Straus and Hancock, 2006). These include, but are not limited
to, the recruitment and/or activation of immune cells, angiogen-
esis and wound healing, dendritic cell maturation, and control-
ling inflammation and sepsis. For example, a-defensins located
in human neutrophils (Rehaume and Hancock, 2008) attract
peripheral T cells found in human blood that express
CD4/CD45RA and CD8 antigens and also attract immature
dendritic cells (Chertov et al., 2000; Zasloff, 2002). HDPs also
exhibit indirect antimicrobial activities and reduce proinflamma-
tory responses through alteration of host-gene expression,
chemotactic activities, and inhibition of lipopolysaccharide
(LPS) induced proinflammatory cytokine production. It has
been demonstrated that these peptides can be expressed either
in response to the presence of bacterial LPS or inflammatory
mediators such as interleukin (IL)-6 or tumor necrosis factor
(TNF)-a (Diamond et al., 1996; Zhang et al., 2000a), although
others appear to be constitutive. Also, HDPs can sequester
LPS shed from Gram-negative bacteria and/or indirectly
antagonize LPS mediated cell signaling, preventing the
induction of inflammatory responses which, if left unchecked,
can lead to potentially deleterious conditions such as sepsissevier Ltd All rights reserved
Table 1. Antimicrobial Activities of the Peptides Used in This
Study
Name Sequence
MIC (mg/ml)
ReferenceP. aeruginosa S. aureus
Bac2A RLARIVVIRVAR 50 17 Hilpert et al. (2005)
W3 RLWRIVVIRVAR 8 2 Hilpert et al. (2005)
1018 VRLIVAVRIWRR 19 5
1019 IVVWRRQLVKNK >300 >300
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peptides have been shown to depend absolutely on uptake
into eukaryotic cells (Lau et al., 2005; Mookherjee et al., 2009;
Nijnik et al., 2010; Yu et al., 2009), with two intracellular receptors
recently described (Mookherjee et al., 2009; Yu et al., 2009).
These peptides all bear the hallmarks of cell penetrating
peptides in carrying a net positive charge (often due to arginine
residues) and amphipathicity. Although much is known about
how HDPs interact with membranes (see, e.g., Haney et al.,
2009; Sitaram et al., 2002), little is known about how HDP struc-
ture correlates with the immunomodulatory functions of these
peptides.
In recent years, there has been an increased effort to design
and develop synthetic peptides, termed innate defense regula-
tory peptides (IDRs), with enhanced immunomodulatory activi-
ties, using natural HDPs as templates. Examples include the
peptide Bac2A, a linear derivative of the cathelicidin bactenecin
found in bovine neutrophils (Bowdish et al., 2005b; Wu and
Hancock, 1999a), the synthetic immunomodulatory peptides
IDR-1 (Haney et al., 2009) and IDR-1002 (Nijnik et al., 2010), as
well as many others (Avrahami and Shai, 2004; Haney et al.,
2009; Porcelli et al., 2006; Stro¨mstedt et al., 2009). Recently,
new synthetic peptide libraries have been generated using the
quantitative structure-activity relationship (QSAR) methodology
(Nijnik et al., 2010). This approach exploits the relationship
between higher order sequence motifs or contexts and peptide
antimicrobial activity to yield lead peptide candidates with
optimized activities (Cherkasov et al., 2009). Recently (H.J. and
R.E.W.H., unpublished data) a series of peptides, derived from
the base sequence of the 12 amino acid antimicrobial and immu-
nomodulatory peptide Bac2A (Wu and Hancock, 1999a),
through point substitutions, scrambling, and deletions were
iteratively tested for their ability to stimulate immune responses
ex vivo, as monitored through elevation of the cytokine/chemo-
kine profile in human peripheral blood mononuclear cells
(PMBCs) and confer protection to bacterial challenge in vivo.
Of the many peptides generated, peptide IDR-1018 (VRLIVAV-
RIWRR; abbreviated here as 1018) was a promising candidate
with moderate minimal inhibitory concentrations (MIC), minimal
hemolytic activity, and a significant reduction in the LPS induced
TNF-a response. Interestingly, of the dozens of peptides gener-
ated and tested by us to date, 1018 had the highest effect on the
induction of chemokines ex vivo as measured by MCP-1 and
MCP-3 expression. Intriguingly, 1018 turned out to be distantly
related to Bac2A (Wu and Hancock, 1999a, 1999b) in that 1018
has nearly identical amino acid composition to Bac2A (RLARIV-
VIRVAR), namely, three Val, four Arg, one Leu, two Ile, one Ala,
with one A/W substitution and scrambling of the peptide
sequence.
To better understand the structure-function relationships of
peptide 1018, we have characterized the structure of this
peptide in model membranes consisting of lipids with neutral
head groups (zwitterionic dodecyl phosphocholine (DPC)
micelles, as an analog) and lipids with a mixture of neutral and
negatively charged head groups (phosphatidylcholine/phospha-
tidylglycerol, model for bacterial cells, and sodium docecyl
sulfate [SDS] as an analog) by solution state NMR and CD.
We have also quantified the immunomodulatory functions of
1018 by examining its ability to induce chemokine responsesChemistry & Biology 17, 970–9ex vivo, its antiendotoxin activity, and its cytotoxicity. Also we
have determined the MIC of 1018 required to kill both Gram-
positive Staphylococcus aureus and Gram-negative Pseudo-
monas aeruginosa. Our findings are compared to those obtained
for Bac2A, peptide W3, an A3W substitution of Bac2A and
a sequence scrambled version of 1018 (Hilpert et al., 2005),
and an inactive peptide from our IDR library, denoted 1019
(Table 1).
RESULTS
Chemokine Profile
The immunomodulatory activities of synthetic IDRs are reflected
in part by their ability to induce chemokines in PBMCs (Nijnik
et al., 2010); previous studies have indicated that this activity is
related to their ability to protect against infections (Yu et al.,
2009; Cherkasov et al., 2009). Peptide 1018was therefore tested
for its ability to induce responses for the chemokines Gro-a
(Figure 1A), MCP-1 (Figure 1B), and MCP-3 (Figure 1C) in human
PBMCs. The results demonstrated an 8- to 99-fold increase in
chemokine induction at 100 mg/ml and >50-fold at 20 mg/ml as
compared with Bac2A and the negative control peptide 1019,
whereas W3, a sequence scrambled version of 1018, was only
modestly less efficient at chemokine induction. Overall, peptide
1018 exhibited more than 10-fold enhanced chemokine-
inducing activities compared with the synthetic peptide IDR-1
(Barlow et al., 2006; Scott et al., 2007) and much greater activi-
ties than the (effectively) sequence scrambled parent Bac2A
which caused only a 3-fold increase in MCP-1 concentration at
100 mg/ml.
As any immunomodulatory activities of peptides must be
tempered with an appreciation for their associated cytotoxic-
ities, 1018 was also tested for host cell toxicity by monitoring
hemoglobin release from RBCs as an indicator of loss of cell
membrane integrity. At the very high concentration of
375 mg/ml of 1018, only a slight toxic effect was observed with
lysis of 14.4% of the red blood cells after 24 hr exposure, while
no lytic effect was observed at the concentrations used to
demonstrate chemokine induction and no release of lactate
dehydrogenase from human PBMCs at concentrations of up to
200 mg/ml, cf. the human cathelicidin LL-37 which demonstrates
cytotoxicity at levels above 25–50 mg/ml (Barlow et al., 2006).
Antiendotoxin Activity
Several IDR peptides have been shown to suppress proinflam-
matory responses in response to the Gram-negative bacteria
signature molecule lipopolysaccharide (LPS) (Bowdish et al.,
2005b; Mookherjee et al., 2006a, 2006b; Scott et al., 2007).80, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 971
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Figure 1. Profile of Relative Fold Change Expression of Gro- a,
MCP-1, and MCP-3
(A) Gro-a, (B) MCP-1, and (C) MCP-3 from PBMCs monitored at two concen-
trations of 20 (light gray) and 100 (dark gray) mg/ml for peptide 1018 (VRLIVAV-
RIWRR), peptide 1019 (IVVWRRQLVKNK), W3 (RLWRIVVIRVAR), and Bac2A
(RLARIVVIRVAR). The results represent mean ± SD of three biological
replicates.
Figure 2. Suppression of LPS-Induced TNF-a in Human Peripheral
Blood Mononuclear Cells
PBMCs were incubated with 20 mg/ml of 1018 for 45 min before the addition of
2 ng/ml P. aeruginosa LPS or vehicle control. TNF-a secretion was measured
after 24 hr incubation at 37C. The results represent mean ± SD of three bio-
logical replicates. Peptide (alone) control gave no significant induction of
TNF-a compared with the control (untreated cells); data not shown. The
percentage reduction of antiendotoxin activity of 1018 is 89%.
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proinflammatory TNF-a response induced by LPS in human
PBMCs. Earlier studies have shown that the induction of
TNF-a in response to LPS peaks at 4–8 hr (Scott et al., 2007).972 Chemistry & Biology 17, 970–980, September 24, 2010 ª2010 ElWe therefore measured effects of these peptides after 4 hr in
the current study.
By itself, 1018 did not demonstrate a significant increase in
TNF-a secretion above the background (negative control).
However at a concentration of 20 mg/ml, 1018 reduced the
LPS-induced TNF-a response by 89% (Figure 2). In contrast at
a higher concentration of 50 mg/ml, Bac2A caused only 18%
reduction in TNF-a while the scrambled peptide W3 caused
only 37% reduction in LPS-stimulated TNF-a production. To
determine whether the antiendotoxic response of 1018 was
mediated through the direct interaction of the peptides with
LPS, the ability of the peptide to directly bind to P. aeruginosa
LPS was evaluated using a standard dansyl Polymyxin B
displacement assay (Fidai et al., 1997; Moore et al., 1991). The
peptide displayed no significant binding to LPS (data not shown)
indicating that it worked through indirect modulation of proin-
flammatory responses as suggested in part for LL-37 (Mookher-
jee et al., 2006a).
Peptide Direct Antibacterial Activity
The immunomodulatory peptide IDR-1 was deliberately
designed to exclude any potential antimicrobial activity (Cherka-
sov et al., 2009). This was not a factor in the design of 1018.
Peptide 1018 was screened for activity against both a Gram-
negative and Gram-positive bacteria using a modified NCLSA
method. The peptide had superior activity to Bac2A, but was
less potent than the scrambled peptide W3. Although not
particularly potent, 1018 demonstrated a reasonable activity
against Gram-positive organism S. aureus with an MIC of
5 mg/ml, but was significantly weaker against the Gram-negative
P. aeruginosa (MIC of 19 mg/ml) (Table 1). The inactive peptide
1019 had MICs of greater than 300 mg/ml for both Gram-positive
and Gram-negative organisms used above.
QSAR is an important computational tool in peptide design
that seeks to relate physicochemical peptide parameters
through descriptors that describe the biological activities of the
peptide. Much work has been invested in developing robust
QSAR solutions for predicting antimicrobial activity of synthetic
peptides (Cherkasov et al., 2009; Nijnik et al., 2010). All of thesesevier Ltd All rights reserved
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(a peptide library) to secure a robust model, thus making it diffi-
cult to do similar QSAR on the isolated set of peptides described
in Table 1. To circumvent this, we used a predictive model of the
relationship between antimicrobial activity and peptide structure
(reflected through the use of multiple physical chemical and
inductive ‘‘descriptors’’) that was built on a library of Bac2A-
related peptides (H.J. and R.E.W.H., unpublished data) to
predict the activity of Bac2A, W3, and 1018. The model pre-
dicted a 2-fold increase in activity between Bac2A and 1018,
and between 1018 and W3, matching the observed activities
fairly well.
Structure of 1018 in Mammalian Model Membranes
Mammalian cell surface membranes usually comprise largely
uncharged lipids. Consequently, a number of structural studies
of antimicrobial peptides have used DPC as a model for
mammalian membranes. Examples include indolicidin (Rozek
et al., 2000), maximin H6 (Kosol and Zangger, 2010), fallaxidin
4.1a (Sherman et al., 2009), and a number of other peptides
(Porcelli et al., 2008; for a recent review, see Haney et al., 2009).
CD spectra were recorded for 1018, 1019, Bac2A, and W3 in
DPC micelles to determine the structure these peptides adopt
in the presence of uncharged lipids. The spectra clearly showed
that 1018 adopts an a-helical conformation in this environment
(Figure 3B, black), as do Bac2A and W3. A fit of multiple CD
spectra using the programs CDSSTR (Johnson, 1999),
CONTINLL (Provencher and Glockner, 1981), and SELCON3
(Sreerama et al., 1999; Sreerama and Woody, 1993, 1994)
revealed that 70%–98% of peptide 1018 (or 9–12 residues) is
helical. W3 and Bac2A also displayed a similar degree of helical
content, but the different mean residue ellipticities obtained in
the CD spectra of W3 and Bac2A as compared with 1018
suggest that these two peptides did not bind DPC membranes
as well as did 1018, or that 1018 interacted in a somewhat
more intimate fashion. Recent studies on LL-37 have shown
that binding between LL-37 and membranes occurs via the
aromatic residue F17 (Porcelli et al., 2008; Wang, 2010). Since
Bac2A does not contain a single aromatic residue, this may
explain why the interactions between DPC and Bac2A are
observed to be weaker. The weak interaction between DPC
and W3 (which contains one tryptophan) may be due to the
fact that the aromatic residue is located close to the N terminus.
In LL-37, theN terminus ismore dynamic and less structured that
the C terminus (Porcelli et al., 2008). It is worth mentioning that
for certain immunomodulatory activities peptides need to trans-
locate into immune cells (Cherkasov et al., 2009; Yu et al., 2009),
and we propose that the different ellipticities might reflect
propensity to translocate across membranes, a property
common to many, but not all, cationic amphipathic peptides
rich in arginine residues.
To further quantify the structure of 1018 in DPCmicelles, solu-
tion state NMR spectra of 1018 in DPC micelles were recorded.
Standard homonuclear methods were used to determine the full
three-dimensional structure of this peptide (Wuthrich, 1986).
Spectra were acquired using total correlation spectroscopy
(TOCSY) and nuclear Overhauser enhancement spectroscopy
(NOESY) experiments, in phase-sensitive mode using time
proportional phase incrementation (TPPI) (Marion and Wuthrich,Chemistry & Biology 17, 970–91983) in the indirect dimension. A total of 116 unambiguous
NOEs were found and used in the structure refinement (see
Table S1 available online), using a previously established
protocol (Lewis et al., 2007). The large number of i to i+4 and
i to i+3 NOE contacts found supported the CD findings
(Figure 4A). The resulting family of structures is shown in
Figure 4B. The R2 to W10 segment of 1018 was in an a-helical
conformation.
Structure of 1018 in Bacterial Model Membranes
Bacterial membranes have varied composition depending on
whether the bacteria are Gram-positive or Gram-negative
(Epand et al., 2007). In all cases, however, a certain proportion
of the lipids contain negatively charged head groups. Therefore,
anionic lipids, such as SDS or mixtures of POPE/POPG (Epand
et al., 2006) or POPC/POPG are typically used asmodel bacterial
membranes. A number of studies on antimicrobial peptides
using these lipids can be found in the literature (Jung et al.,
2008; Ramamoorthy et al., 2006) and have been recently re-
viewed in Haney et al. (2009).
In strong contrast to the structure in DPC micelles, the CD
spectra of 1018 in SDS and 1:1 POPC/POPG (Figures 3D and
3E) demonstrated that the peptide adopts a b turn conformation.
The spectra for Bac2A and the W3mutant of Bac2A yielded very
similar spectra under the same conditions. Interestingly, the
peptide 1019, which displayed no antimicrobial activity, did not
adopt any structure in the presence of SDS or POPC/POPG.
Structural Plasticity of 1018
Since the CD data above clearly indicate that 1018 can adopt
different conformations in different environments, a local eleva-
tion molecular dynamics simulation was run on 1018 to qualita-
tively determine how easily the peptide could interconvert from
one structure to the other. The simulation was run in water,
with a starting configuration of a straight a helix. The structures
sampled during the course of the simulation are shown in Figure 5
and indicated that the peptide can adopt a range of configura-
tions, some of which are reminiscent of a b turn conformation.
Overall, the simulation showed that 1018 rapidly unfolds in
water, consistent with the CD data for 1018 in buffer, which indi-
cated that 1018 adopts a random coil conformation under these
conditions.
Membrane Perturbation Ability of 1018
Differential scanning calorimetry (DSC) experiments were per-
formed to determine whether 1018 functions by perturbing
membrane bilayers. The neutral lipids DMPC and a mixture of
1:1 DMPC/DMPG were chosen as models for mammalian and
bacterialmembranes, respectively, as used in anumber of studies
in the literature (Lohner et al., 1999; Pabst et al., 2008). In addition,
the lipidDiPoPEwas used to examinewhether 1018has the ability
to induce membrane curvature (Jung et al., 2008).
The DSC thermograms of 1018 in DMPC alone (Figure S1A),
DMPC/DMPG (1:1) (Figure S1B), and DiPoPE (Figure S2) illus-
trated that this peptide did not significantly perturb model
membranes, except at very high (nonphysiological) concentra-
tions. This is in contrast to LL-37 which has been found to induce
positive membrane curvature in DiPoPE membranes (Henzler
Wildman et al., 2003). This suggests that 1018 most likely80, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 973
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Figure 3. Secondary Structure of 1018, 1019, Bac2A, and W3 from Circular Dichroism
The CD spectra of 1018 (black), 1019 (dark gray), Bac2A (gray), and W3 (light gray) were obtained in (A) phosphate buffer, (B) DPC micelles, (C) 10 mM Tris, (D) in
10 mM SDS micelles (in 10 mM Tris), and (E) 1:1 POPC/POPG vesicles (470 mM) in 10 mM Tris. In (B), 100 mM peptide was mixed with 7.5 mM DPC in 750 mM
phosphate buffer (pH 7.3). All peptides are unstructured in buffer alone. Peptide 1019 does not adopt any structure in the presence of DPC, whereas the other
three peptides adopt a-helical structure in DPC. In (C)–(E), 0.07 mM of peptide was used. The spectra in (D) and (E) reveal that the peptide 1018 adopts a b turn
conformation, as does Bac2A and W3. The peptide 1019 is unstructured in (C)–(E).
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an intracellular target or by some othermeans (e.g., by interfering
with bacterial machineries responsible for producing the cell wall
or for performing functions in cell division, energy transduction,
or active transport).
DISCUSSION
With the alarming increase in the number of cases of multidrug-
resistant bacterial infections such as methicillin-resistant974 Chemistry & Biology 17, 970–980, September 24, 2010 ª2010 ElS. aureus (MRSA) and vancomycin-resistant enterococci (VRE),
it has become important to develop novel anti-infectives. An
interesting class of compounds being developed is the cationic
host-defense peptides. These peptides are integral components
in the defense mechanisms of all living organisms. Interest in the
therapeutic potential of HDPs is due to their demonstrated
collective ability to kill bacteria by direct antimicrobial action or
modulation of host immunity, and their limited induction of
bacterial resistance patterns. To date, however, most studies
have looked at one or the other of these properties and directsevier Ltd All rights reserved
AB
Figure 4. NMR Structure of 1018 in DPC
(A) NOE connectivities observed for 1018. White boxes represent connectivi-
ties that may be present, but are overlapped with other resonances.
(B) Representative structure of 1018 determined using NOE refinement. The
structure shown is that of the representative structure of cluster 0, the most
dominant configuration. The thickness of the worm in green was generated
by taking the coordinates of each representative structure of clusters 0..18
and weighting them according to cluster size (see experimental procedure
for details).
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exploited in clinical trials (Jenssen and Hancock, 2010).
In this communication, we have investigated the role of struc-
ture and function with the peptide 1018, which was one of most
potent immunomodulatory peptides obtained from a recently
designed library. This peptide was chosen for further study
here because, unlike IDR-1 (Scott et al., 2007), it also has
moderate antibacterial activity. As the experimental data
(Figures 3 and 4) illustrate, and the local elevation simulations
(Figure 5) suggest, 1018 is unstructured in water but can adopt
different structures in different membrane environments. In
model membranes that comprise largely lipids with neutral or
zwitterionic head groups, the CD and solution state NMR data
showed that 1018 adopted a helical structure. In anionic model
membranes, the CD data indicated that 1018 adopted a b turn
structure. Interestingly, both Bac2A and W3 also adopted
a helical structure in DPC and a b turn structure in SDS andChemistry & Biology 17, 970–9POPC/POPG. In contrast, 1019 did not adopt any structure, be
it in buffer, DPC, SDS, or POPC/POPG vesicles.
The peptides that displayed bactericidal activity adopted the
same fold in the different environments, despite the fact that their
activities are varied, with W3 being the most effective antimicro-
bial peptide, followed by 1018, and then Bac2A (Table 1). This
structural similarity may suggest that the choice of the model
membrane is not optimal to gain insight into subtle changes
in activity or correspondingly that very small differences in struc-
ture can have substantial impacts on activity. Although POPC/
POPG is commonly used as a bacterial model membrane (Cheng
et al., 2009; Jung et al., 2008; Ramamoorthy et al., 2006; Rama-
moorthy, 2009; Su et al., 2008), some studies have suggested
that POPE/POPG or other lipid mixtures may be better systems
(Chen et al., 2005; Epand and Epand, 2009; Epand et al., 2008;
Kline et al., 1987; Salnikov et al., 2008). On the other hand, the
strong similarities in amino acid composition of Bac2A, 1018,
and W3 may indicate why these three peptides adopt the
same structure in an anionic lipid environment, regardless of
the exact nature of the lipid head group and the order of the
amino acids in the sequence. Alternatively the differences in
activity of the active peptides must relate to another property
afforded by their different structures and do not reflect just their
ability to adopt particular confirmations (although results with
1019 suggest that restructuring in membranes is important). It
is worth noting that peptide activities are likely directed by their
ability to translocate into cells and/or bind to various targets,
and we propose that this is the main feature that differentiates
these active peptides.
The immunomodulatory activities of 1018, Bac2A, and W3
were also very different. Bac2A was a very weak inducer of che-
mokines (Figure 1) and had no practical antiendotoxic activity,
consistent with previous studies (Bowdish et al., 2005b).
W3, on the other hand, induced substantial expression of
MCP-1 at doses of 100 mg/ml but lower than that of 1018
(Figure 1), while antiendotoxic activity was minimal. The CD
data showed that all three peptides adopted an a-helical confor-
mation, but differences in the observed mean residue ellipticities
(Figure 3B) suggest that the peptidesmay bind differently to DPC
micelles, with 1018 binding the best. This may account for the
differences in activity observed. It is also important to note that
the differences in immunomodulatory activity may be related to
the ability of the peptides to remain monodisperse. Attempts
to solve the structure of Bac2A and W3 in detergent DPC
micelles (and mixed DPC/SDS micelles) failed because the
samples aggregated.
The results with 1019, a poor immunomodulatory and antimi-
crobial peptide with reasonably strong amino acid compositional
relationship to that of the other peptides (but more polar), lend
support to the notion that the ability of a peptide to interact
with, bind, and translocate through the membranes is an impor-
tant factor in determining activity. Host-defense peptides (HDPs)
are known to be short amphiphilic peptides, with positive side
chains interacting with lipid head groups. In both a model of
a fully helical structure of 1018 (Figure 6A) and the NMR-derived
structure presented in Figure 4B, the positively charged side
chains are located on one face of the helix, whereas the hydro-
phobic residues are on the other. On the other hand, if the struc-
ture of the inactive peptide 1019 ismodeled as a helix (Figure 6B),80, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 975
Figure 5. Representative Structures Resulting from a Cluster Analysis of the Free Simulation of 1018 in Water
The structures and their corresponding percentage of occurrence in the simulation are, from left to right, (top row) cluster 0: 30.0%, 1: 10.5%, 2: 10.0%, 3: 9.0%,
4: 5.5%, 5: 4.5%; (middle row) cluster 6: 4.0%, 7: 3.5%, 8,9: 2.5%, 10,11: 2.0%; (bottom row) clusters 12,13: 2.0%, 14–16: 1.5%, 17: 0.5%. The structure starts as
a pure helix (cluster 4, shown in red) but rapidly (in 1 ns, data not shown) unfolds in solution. Some structures are reminiscent of b turns.
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ing a weakened interaction between peptide and membrane
bilayer.
Overall, the data presented here suggest that 1018 acts as
a direct antimicrobial peptide despite inducing minimal
membrane perturbation. This indicates that 1018 translocates
in a b turn structure through the membrane to perturb an internal
target. When 1018 acts as an immunomodulator, it adopts an
a-helical structure. Since it appears that translocation across
mammalian membranes is required for chemokine induction
(Lau et al., 2005; Mookherjee et al., 2009; Nijnik et al., 2010; Yu
et al., 2009), this indicates that the a-helical structure might be
optimized for translocation across mammalian membranes,
consistent with other studies (Fischer et al., 2000). Interestingly,
however, different cell penetrating peptides can adopt different
configurations (Deshayes et al., 2004; Magzoub et al., 2001).
The ease with which 1018 interconverts between the two struc-
tures may be linked to the two functions of 1018 and/or may be
required to ensure interaction with targets after the peptide has
translocated into cells.
Overall, this manuscript demonstrates that the order and
specific nature of amino acids within a peptide sequence deter-
mine not only the way they interact with membranes but the
downstream consequences of that interaction. This means that
quite modest changes (a single A to W substitution going for
Bac2A to W3) can have enormous impact, while complete
scrambling can be relatively benign (cf. W3 and 1018). Previous
studies on Bac2A scrambled peptides have demonstrated that
sequence scrambling and single amino acid substitutions can
result in peptides that vary from considerably more active to
completely inactive with respect to antimicrobial activity (Hilpert
et al., 2006). While this considerably complicates informed
design of such molecules, the application of QSAR methods to976 Chemistry & Biology 17, 970–980, September 24, 2010 ª2010 Elthis group of peptides is at least providing predictive methods
that can be used to predict function based on structure.
SIGNIFICANCE
We have combined structural and functional studies to
demonstrate the link between structure and the ability of
1018 to potently induce chemokine responses, suppress
the LPS-induced TNF-a response, and directly kill both
Gram-positive and Gram-negative bacteria. We have also
demonstrated that QSAR methods can be used to predict
function based on the structure of such peptides, but that
factors such as the order and the specific nature of amino
acids within the peptide sequence need to be considered
in the design of molecules that possess both immunomodu-
latory and antimicrobial activity.
EXPERIMENTAL PROCEDURES
Peptide Synthesis
The peptide 1018 (VRLIVAVRIWRR-CONH2) was synthesized by GenScript
(Piscataway, NJ) using solid phase Fmoc chemistry and purified to
a purity >95% using reverse phase HPLC. Peptide mass was confirmed by
mass spectrometry.
Cell Isolation and Peptide Stimulation
Venous blood from healthy volunteers was collected in Vacutainer collection
tubes containing sodium heparin as an anticoagulant (BD Biosciences), in
accordance with University of British Columbia ethical approval and guide-
lines. Bloodwas dilutedwith an equal volume of complete RPMI 1640medium,
supplemented with 10% (v/v) heat-inactivated FBS, 2 mM L-glutamine, and
1 mM sodium pyruvate (all from Invitrogen Life Technologies) and separated
by centrifugation over a Ficoll-Paque Plus (Amersham Biosciences) density
gradient. The buffy coat was collected and washed twice in RPMI 1640
complete medium, and the number of PBMCs was determined by trypansevier Ltd All rights reserved
Figure 6. Representative Models of 1018 and 1019
Comparison of a model of (A) 1018 as an a helix and (B) 1019 in the same
conformation. The model for 1018 is the starting structure used for the molec-
ular dynamics simulations (red helix in Figure 5). The model for 1019 is gener-
ated using the swapaa command in CHIMERA (Pettersen et al., 2004).
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(Falcon; BD Biosciences) at 13 106 cells/ml at 37C in 5%CO2, and rested for
1 hr. The cells were then exposed to peptide at 50 mg/ml for 24 hr. All experi-
ments involved at least three biological replicates.
The red blood cells are left at the bottom of the Ficoll-Paque Plus density
gradient. These cells are then pooled together and washed three times in
saline and used for hemolysis assay/toxicity testing.
Detection of Chemokines
Following 24 hr of exposure to the peptide, the tissue culture supernatants
were centrifuged at 16,000 3 g (13,000 rpm) at 4C for 5 min in an IEC Micro-
Max centrifuge to obtain cell-free samples. Supernatants were aliquoted and
then stored at –20C before assay for various chemokines. MCP-1, MCP-3,
and Gro-a secretion in the tissue culture supernatants were detected by sand-
wich ELISA kits (BioSource International and eBiosciences, respectively).
All assays were performed in triplicate. The concentration of the chemokines
in the culture medium was quantified by establishing a standard curve with
serial dilutions of the recombinant human MCP-1, MCP-3, or Gro-a, respec-
tively. Secretion of TNF-a was monitored in rested PMBCs and cells were
exposed to 20 mg/ml of peptide and/or 2 ng/ml of LPS (P. aeruginosa) by
capture ELISA after 24 hr (eBiosciences).
Cytotoxicity Assessment
The toxic effect of the peptides was assessed by analyzing their potential for
causing hemoglobin release from human red blood cells as a result of cell lysis.Chemistry & Biology 17, 970–9The red blood cells were washed three times in sterile 0.85% NaCl (saline) and
centrifuged at 500 3 g (1500 rpm) for 10 min. Concentrated red blood cells
were diluted 1/3 in saline and 150 ml of this cell suspension was mixed with
50 ml of peptide (4.4–251 mM), diluted in a mixture of 0.01% acetic acid, and
0.2% bovine serum albumin (BSA). Triton X-100 (1%) was used as a positive
control, demonstrating 100% cell lysis. Sterile saline was used as a negative
control. The assay was carried out in 96 well polypropylene microtiter plates
(COSTAR Cat. No. 3790). The red blood cells and peptide dilutions were incu-
bated on a rocking table to obtain circulation at 37C under 5% CO2 pressure
for 24 hr. Light absorbance properties have beenmonitored at 414 and 546 nm
using the ELISA plate reader/spectrophotometer.
PBMCs (2 3 105) were seeded into 96 well plates (Sarstedt, Newton, NC)
and incubated at 37C in 5% CO2 overnight. The release of cytosolic LDH
was then assessed after 24 hr of incubation with peptide 1018 using concen-
trations up to 200 mg/ml. All experiments were done in triplicate.
Minimal Inhibitory Concentration Determination
The MIC of the peptides was measured using a modified broth microdilution
method in Mueller Hinton (MH) medium (MHB, Cat. No. 0757-17-6, DIFCO)
(Wiegand et al., 2008). In brief, the peptides were dissolved and stored in glass
vials. The assay was performed in sterile 96 well polypropylene microtiter
plates (Cat. No. 3790, COSTAR). Serial dilutions of the peptides to be assayed
were performed in 0.01% acetic acid (Cat. No. A-38-4, FISHER) containing
0.2% BSA (Cat. No. 735086, Boehringer Mannheim GmbH) at 103 the desired
final concentration. Ten microliters of the 103 peptides were added to each
well of a 96 well polypropylene plate containing 90 ml of MH media per well.
Bacteria obtained from an overnight culture were added to the plate at
a concentration of 2–7 3 105 CFU/ml and incubated overnight at 37C. The
MIC was taken as the concentration at which no growth was observed.
MIC analysis was done on Gram-negative P. aeruginosa PAO1 strain H103
(Hancock and Carey, 1979) and Gram-positive S. aureus (ATCC#25923) kindly
provided by David Speert (Department of Pediatrics, University of British
Columbia). Both tested bacterial strains were categorized as biohazard level
2 pathogens.
CD Spectroscopy
The lipids sodium dodecyl sulfate (SDS), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidyl-
choline (POPG), and dodecyl phosphocholine (DPC) were purchased from
Avanti Polar Lipids, Inc. (Alabaster, NY). Final sample volumes for CD were
500 ml. POPC/POPG (1:1 molar ratio) and DPC were dissolved with CHCl3 in
round-bottomed flasks. The final lipid concentrations were 470 or 1880 mM
for POPC/POPG, and 7.5 mM for DPC. CHCl3 was evaporated under a stream
of air and the residual solvent was removed under vacuum for at least 12 hr.
The dried DPC film was resuspended in 750 mM phosphate buffer [pH 7.4],
while POPC/POPGwas resuspended in 10mMTris buffer [pH 7.4]. For studies
with SDS, powdered lipid was dissolved in 10 mM Tris [pH 7.4]. Peptide was
weighed and added to the solutions in concentrations of 70 and 100 mM for
studies in Tris and phosphate buffers, respectively. All samples were soni-
cated for at least 30 min in a 40C water bath and used within 48 hr of prepa-
ration.
CD measurements were done on a Jasco J-810 spectropolarimeter equip-
pedwith a temperature control unit located at the UBCLaboratories for Molec-
ular Biophysics. Each sample was vortexed for at least 10 s prior to loading into
the cuvette. The volume placed in the cuvette (width of 1 mm) was 200 ml.
Experiments were done at 35C with a scan rate of 50 nm/min. The ellipticity
was measured every 0.5 nm from 250 to 185 nm. At least three scans per
sample were taken and averaged afterward. All CD spectra were baseline cor-
rected by subtracting a blank solvent scan.
NMR Spectroscopy
The NMR sample consisted of 1 mM 1018 in 75 mM DPC, 7.5 mM phosphate
buffer, and 8% D2O (v/v) [pH 7], in a final volume of 600 ml. The sample was
sonicated at 40C for 30 min prior to the start of the NMR experiment.
The spectra were recorded on a Varian Unity500 spectrometer operated by
the UBC Laboratory for Molecular Biophysics. Homonuclear TOCSY (spin lock
time = 70 ms) (Braunschweiler and Ernst, 1983), NOESY (tm = 150 ms) (Jeener
et al., 1979), and ROESY (spin lock time = 74 ms) (Bax and Davis, 1985;80, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 977
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1992) was used for water suppression in this case and the data matrices
were 2k by 512. The spectra were referenced to external DSS and processed
to yield a 2k 3 1k point matrix. The spectra were converted to Bruker format
and analyzed using TOPSPIN.Structure Calculation and Molecular Dynamics Simulations
The GROMOS96 biomolecular simulation package and the 45A3 force field
were used (Scott et al., 1999; van Gunsteren et al., 1996). All simulations
were performed in explicit SPC water (Berendsen et al., 1981) under rectan-
gular periodic boundary conditions in the NPT ensemble (T = 300 K,
p = 1atm) imposed by the Berendsen weak coupling methods (Berendsen
et al., 1984). Covalent bonds were constrained using the SHAKE method
(Ryckaert et al., 1977) with a relative geometric tolerance of 104. A reaction
field long-range correction (Tironi et al., 1995) to the truncatedCoulomb poten-
tial was applied. For the initial coordinates, residues 110–121 were taken from
PDB entry 1CWQ (this section is a straight a helix) andmodified into the appro-
priate residue types using CHIMERA (Pettersen et al., 2004). This structure
was solvated and minimized, after which the system was rendered neutral
by the addition of 4 Cl- ions. After a second minimization step, initial atomic
velocities were generated from a Maxwell-Boltzmann distribution at 300 K
and the system was equilibrated for 500 ps with positional restraints on all
Ca atoms.
Two separate simulations, each 20 ns in length, were performed starting
from this equilibrated system without any positional restraints for data collec-
tion. In the first (designated as the ‘‘free simulation’’), the system was allowed
to evolve under its unmodified Hamiltonian. In the second (designated as the
‘‘refinement simulation’’), the experimentally determined NOE distance
restraint (Table S1) data were introduced into the simulation using a time-aver-
aged potential energy function (Torda and vanGunsteren, 1991) with the relax-
ation time tdr = 1 ps and force constant Kdr = 400 kJ.mol
-1.nm-2 (Nanzer et al.,
1995).
Two hundred configurations, selected at 100 ps time intervals, were
selected from the two simulations and subjected to a cluster analysis as previ-
ously described (Scott et al., 2006), where the clustering cutoff was set to
0.048 nm (refinement simulation) and 0.135 nm (free simulation) and all Ca
atoms were considered in the distance metric.
For the refinement simulation, the cluster analysis resulted in 39 clusters, of
which the largest were chosen such that the accumulated percentage is larger
than 90% of the sampled 200 structures. This resulted in 19 clusters, labeled
0–18, in decreasing size (cluster 0:36.5%, 1: 20.5%, 2: 5.0%, 3: 5.0%, 4: 4.0%,
5: 4.0%, 6: 2.5%, 7–11: 1.5%, 12–14: 1.0%, 15–18: 0.5%). The representative
structure from cluster 0 is shown in Figure 4B.
For the free simulation, the cluster analysis resulted in 28 clusters, of which
the largest were chosen such that the accumulated percentage of the sampled
200 structures is larger than 95%. This resulted in 18 clusters, denoted cluster
0–17, the representative structures of which are depicted in Figure 5.Differential Scanning Calorimetry
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-
glycero-3-[phospho-rac-(1-glycerol)] (DMPG), and 1,2-dipalmitoleoyl-sn-glyc-
ero-3-phosphoethanolamine (DiPoPE) were purchased from Avanti Polar
Lipids, Inc. (Alabaster, NY). All lipids were used as received. For DSC studies
in DMPC/DMPG (1:1 molar ratio) and DMPC alone, lipids were dissolved
in CHCl3 in round-bottomed flasks. The final lipid concentration was
2.5 mg/ml. CHCl3 was evaporated under a stream of air and residual solvent
removed under vacuum for at least 12 hr. The dried lipid films were then resus-
pended in buffer (20mMHEPES, 100mMNaCl [pH 7.0]). Peptide wasweighed
and added to make three samples with peptide:lipid molar ratios of 1:100,
1:50, and 1:15. The samples were then vortexed vigorously for 30 s and placed
in a 45C water bath for 2 min to bring the temperature above the La to HII
phase transition temperature. This was repeated two more times to ensure
the formation of multilamellar lipid vesicles. Samples were degassed for at
least 15min prior to DSC loading. DSC thermogramswere taken on aMicroCal
VP-DSC extended range microcalorimeter located at the UBC Center for Bio-
logical Calorimetry. The scanning rate was 60/min with a 15 min prescan
using high feedback and a 2 s filter time. The scanning range was 5–40C978 Chemistry & Biology 17, 970–980, September 24, 2010 ª2010 Eland samples were only scanned once. All scans were baseline corrected by
subtracting a buffer scan.
For studies in DiPoPE vesicles, lipid and peptide were codissolved in
CHCl3:CH3OH (2:1 v/v) at a peptide to lipid ratio of 1:250 in a glass test
tube. Solvent was evaporated under a stream of air and residual solvent was
removed under vacuum for at least 12 hr. The dried film was resuspended in
buffer (10 mM Tris, 100 mM NaCl, 1 mM EDTA, 0.002% NaN3 [pH 7.4]) to
give a final lipid concentration of 10 mg/ml. Samples were vortexed vigorously
for 30 s with gentle swirling in between; this was repeated twicemore to ensure
vesicle formation. The La to HII phase transition temperatures were recorded
using the same calorimeter as before. Two scans were taken from 10–60C
at a rate of 60/min with a 15 min prescan using high feedback and a 2 s filter.
Only the second scan was deemed suitable for analysis in each case. Buffer
thermograms were subtracted for baseline correction.SUPPLEMENTAL INFORMATION
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